Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject implanted or upgraded with a NG3 or NG4 CRT-D device connected with any manufacturer quadripolar LV lead based on BSC labeling for devices in specific geographies.
Subjects must be enrolled between 1 and 21 calendar days post CRT-D implantation procedure.
Subject is age 18 or above, or of legal age to give informed consent specific to each country and national laws
Subject is willing and capable of complying with follow-up visits and procedures as defined by this protocol
You may not be if
Subject with documented life expectancy of less than 12 months
Subject currently on the active heart transplant list or has a current Left Ventricular Assist Device or other assist device (mechanical circulatory support device).
Subject who have had a pre-existing CRT device
Subject enrolled in any other concurrent clinical trial without prior written approval from BSC Clinical Trial Manager
Women of childbearing potential who are or might be pregnant at time of study enrolment
Any contra-indication to receive a CRT-D device per local guidelines
